Skip to main content
Clinical Trials/NCT04856540
NCT04856540
Completed
Not Applicable

Clinical Characteristic and Quality of Life Assessment in Adulthood of Patients With Cryopyrin Associated Periodic Syndrome

University Hospital, Lille1 site in 1 country54 target enrollmentSeptember 16, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cryopyrin Associated Periodic Syndrome
Sponsor
University Hospital, Lille
Enrollment
54
Locations
1
Primary Endpoint
Clinical characteristics of patients with CAPS in adulthood
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The patients included in this study were followed up in the Internal Medicine and Paediatrics Departments of the Lille CHU, the Paediatric Rheumatology and Immunology Department of the Necker Enfant Malade Hospital in Paris and the Paediatric Rheumatology Department and Internal Medicine of the Bicêtre Hospital in Paris. All patients selected presented one of the 3 CAPS clinical phenotypes (CINCA/NOMID, Muckle-Wells or Cold Urticaria). The mutation and the determination of the variant had to be confirmed by genetic analysis.

Patient data were collected from their medical records, retrospectively. Data collected concern childhood period from appearance of symptoms, adulthood period, in the last year and patients' way of life and quality of life upon the assessment. In addition, we collected demographic data related to the patients' lifestyle (intoxications, living arrangements, level of education) and we conducted individual telephone interviews lasting 15 minutes to complete a quality of life questionnaire including the SF36 questionnaire.

The study aimed to describe the clinical symptoms of patients in adulthood and to assess quality of life. We also wanted to compare the clinical phenotypes of patients according to their genetic variant.

Registry
clinicaltrials.gov
Start Date
September 16, 2021
End Date
February 25, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Lille
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of FCAS, Muckle-Wells or NOMID/CINCA;
  • age \< 16 years at the apparition of the first symptoms of the disease;
  • age ≥ 16 years old at inclusion
  • follow-up in a CEREMAIA reference or competence center.

Exclusion Criteria

  • Age \< 16 years at inclusion;
  • non-consenting patient

Outcomes

Primary Outcomes

Clinical characteristics of patients with CAPS in adulthood

Time Frame: Baseline

Secondary Outcomes

  • Assessment of the quality of life of patients with CAPS in adulthood(Baseline)
  • Compare the clinical status between childhood and adulthood(Baseline)
  • Compare the clinical status of patients according to their genetic variant.(Baseline)

Study Sites (1)

Loading locations...

Similar Trials